EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY 4.0

Time-to-start of anticoagulant therapy and mortality in pulmonary embolism

Kelsey E Bria, Brian F Gage, Alejandra Gutierrez, Caleb J Chiang, Jia Qi Xiong, Serena Flórez-Marqués, Cameron Upchurch, Melissa Beasley, Kristen M Sanfilippo

Journal of Thrombosis and Haemostasis · 2026-09 · 24 (9) · 3240-3246

DOI: 10.1016/j.jtha.2026.06.014 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Thrombosis and Haemostasis, 2026-09. Verfasst von Kelsey E Bria und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA. Electronic address: bria.k@wustl.edu. Hauptthemen laut MEDLINE: Anticoagulants, Pulmonary Embolism, Time-to-Treatment. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Heart Lung and Blood Institute, American Society of Hematology Inc, John T. Milliken Department of Medicine, Washington University in St. Louis.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnticoagulantsPulmonary EmbolismTime-to-TreatmentAgedAged, 80 and overFemaleHumansMaleMiddle AgedHeparinHeparin, Low-Molecular-WeightRetrospective StudiesRisk AssessmentRisk FactorsTime FactorsTreatment DelayTreatment Outcome

Stichwörter der Autor:innen

anticoagulantsmortalitypulmonary embolismquality improvementtime-to-treatment

Substanzen

AnticoagulantsHeparinHeparin, Low-Molecular-Weight

Autor:innen und Institutionen

  • Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA. Electronic address: bria.k@wustl.edu.
  • Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Department of Cardiology, University of Minnesota, Minneapolis, Minnesota, USA.
  • University of Puerto Rico-Rio Piedras, San Juan, Puerto Rico.
  • Department of Emergency Medicine, University of Vermont Larner College of Medicine, Burlington, Vermont, USA; Department of Medicine, Division of Pulmonary and Critical Care, University of Vermont Larner College of Medi…
  • Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA; Department of Medicine, St. Louis Veterans Administration Health Care System, St. Louis, Missouri, USA.

Förderung

  • National Heart Lung and Blood Institute
  • American Society of Hematology Inc
  • John T. Milliken Department of Medicine, Washington University in St. Louis
  • American Society for Horticultural Science

Zitieren

APA

Bria, K. E., Gage, B. F., Gutierrez, A., Chiang, C. J., Xiong, J. Q., Flórez-Marqués, S., Upchurch, C., Beasley, M., & Sanfilippo, K. M. (2026). Time-to-start of anticoagulant therapy and mortality in pulmonary embolism. Journal of Thrombosis and Haemostasis, 24(9), 3240-3246. https://doi.org/10.1016/j.jtha.2026.06.014

Vancouver

Bria KE, Gage BF, Gutierrez A, Chiang CJ, Xiong JQ, Flórez-Marqués S, et al. Time-to-start of anticoagulant therapy and mortality in pulmonary embolism. Journal of Thrombosis and Haemostasis. 2026;24(9):3240-3246. doi:10.1016/j.jtha.2026.06.014

BibTeX
@article{Bria2026,
  author = {Bria, Kelsey E and Gage, Brian F and Gutierrez, Alejandra and Chiang, Caleb J and Xiong, Jia Qi and Flórez-Marqués, Serena and Upchurch, Cameron and Beasley, Melissa and Sanfilippo, Kristen M},
  title = {Time-to-start of anticoagulant therapy and mortality in pulmonary embolism},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2026},
  volume = {24},
  number = {9},
  pages = {3240--3246},
  doi = {10.1016/j.jtha.2026.06.014}
}
Kostenlos starten →